16 results
8-K
EX-99.1
BGLC
BioNexus Gene Lab Corp
18 Apr 24
Regulation FD Disclosure
1:44pm
adoption in Healthcare
FOR IMMEDIATE RELEASE
Kuala Lumpur, Malaysia - April 18, 2024 — BioNexus Gene Lab Corporation (NASDAQ: BGLC), a global leader … in genomic diagnostics and healthcare technology, announces a strategic investment by its wholly owned subsidiary, MRNA Scientific Sdn Bhd
8-K
BGLC
BioNexus Gene Lab Corp
1 Apr 24
Departure of Directors or Certain Officers
3:59pm
of HLT Global Berhad since 8 January 2016, which is a publicly listed company involved in the healthcare manufacturing industry. Mr. Wong also sits
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
Berhad since 8 January 2016, which is a publicly listed company involved in the healthcare manufacturing industry. Mr. Wong also sits on the board
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
and has been an independent non-executive director of HLT Global Berhad since 8 January 2016, which is a publicly listed company involved in the healthcare
424B4
69p5npkpp2z5taoe 79u
21 Jul 23
Prospectus supplement with pricing info
3:37pm
10-K
v60mcrerj5 3wjqfbe
31 Mar 20
Annual report
1:12pm
S-1/A
2fk9s k7q
25 Feb 19
IPO registration (amended)
3:30pm
S-1
hqsji78a4yrl2
29 Jan 19
IPO registration
12:00am
- Prev
- 1
- Next